Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 6/20 | 0.48 |
| ▸ | RAB9A | P51151 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.46 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9636315 | 0.98 | SNCA (0.50) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL2876812 | 0.84 | SNCA (0.49) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6421503 | 0.83 | SNCA (0.64) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6421501 | 0.83 | SNCA (0.64) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Benzoxazolinone SCHEMBL31124589 | 0.80 | HDAC3 (0.56) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| Benzoxazolinone SCHEMBL140087 | 0.80 | HDAC3 (0.56) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3083787 | 0.79 | SNCA (0.51) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL223564 | 0.79 | HDAC3 (0.56) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL717590 | 0.79 | SNCA (0.51) | SNCAHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6598835 | 0.79 | HDAC3 (0.56) | SNCAHDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115368713-A | Antibacterial injection molding for automotive interior and preparation method thereof | 扬州维辰汽车电子有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-115216100-A | Anti-ultraviolet injection molding part for automobile interior and preparation method thereof | 扬州维辰汽车电子有限公司 | 2022-10-21 | — | — | CN | claimed |
| US-20150202185-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | TAIJI BIOMEDICAL, INC. | 2015-07-23 | — | — | US | claimed |
| US-20130012539-A1 | Compositions and Methods for Treating Lysosomal Disorders | THE HOSPITAL FOR SICK CHILDREN (CA) | 2013-01-10 | — | — | US | claimed |
| EP-2211856-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | The Hospital For Sick Children (CA) | 2010-08-04 | — | — | EP | claimed |
| EP-1205815-B1 | Liquid inks comprising surface-treated colorant particles and manufacturing method thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2009-12-23 | — | — | EP | claimed |
| EP-2082740-A2 | Use of imidazole derivatives as MDR modulators | Taiji Biomedical, Inc. (US) | 2009-07-29 | — | — | EP | claimed |
| US-20090163500-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-06-25 | — | — | US | claimed |
| WO-2009073564-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-06-11 | — | — | WO | claimed |
| US-20070203215-A1 | Methods & Compositions For Enhancing Pharmaceutical Treatments | TAIJI BIOMEDICAL, INC. (US) | 2007-08-30 | — | — | US | claimed |
| EP-1229057-B1 | Organosol and liquid inks comprising the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-05-23 | — | — | EP | claimed |
| US-20050009952-A1 | Liquid inks comprising a stable organosol | SAMSUNG ELECTRONICS CO. LTD. | 2005-01-13 | — | — | US | claimed |
| EP-0999835-A4 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | ONTOGEN CORP (US) | 2004-08-25 | — | — | EP | claimed |
| US-20020147197-A1 | Methods and compositions for enhancing pharmaceutical treatments | TAIJI BIOMEDICAL, INC. | 2002-10-10 | — | — | US | claimed |
| US-20020128349-A1 | Liquid inks comprising a stable organosol | S-PRINTING SOLUTION CO., LTD. (KR) | 2002-09-12 | — | — | US | claimed |
| EP-1229057-A2 | Organosol and liquid inks comprising the same | Samsung Electronics Co., Ltd. (KR) | 2002-08-07 | — | — | EP | claimed |
| EP-1205815-A1 | Liquid inks comprising surface-treated colorant particles and manufacturing method thereof | Samsung Electronics Co., Ltd. (KR) | 2002-05-15 | — | — | EP | claimed |
| EP-0999835-A1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | Ontogen Corporation (US) | 2000-05-17 | — | — | EP | claimed |
| WO-1999002155-A1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | ONTOGEN CORPORATION (US) | 1999-01-21 | — | — | WO | claimed |
| JP-58025361-A | — | — | None | — | — | JP | disclosed |
| US-12441823-B2 | Resin composition for optical shaping | KURARAY NORITAKE DENTAL INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| WO-2025126917-A1 | DENTAL COMPOSITION | クラレノリタケデンタル株式会社 | 2025-06-19 | — | — | WO | disclosed |
| US-12311036-B2 | Metal oxides nanoparticles conjugated with naphthalene derivatives as contrast agents for the detection of beta amyloid plaques by magnetic resonance images | CENTRO DE NEUROCIENCIAS DE CUBA (CU) | 2025-05-27 | — | — | US | disclosed |
| CN-119775261-A | Collagen 1 translation inhibitors and methods of use thereof | 艾尼莫生物科技公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-115427404-B | Collagen 1 translation inhibitors and methods of use thereof | 艾尼莫生物科技公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240026191-A1 | STYRENE BUTADIENE RUBBER LATEX COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | LIONEL COPLYMER HOLDINGS, LLC (US) | 2024-01-25 | — | — | US | disclosed |
| US-11879072-B2 | Styrene butadiene rubber latex compositions and methods for making and using same | Lion Copolymers Holdings, LLC (US) | 2024-01-23 | — | — | US | disclosed |
| US-20230348762-A1 | STYRENE BUTADIENE RUBBER LATEX COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | LION COPOLYMER HOLDINGS, LLC (US) | 2023-11-02 | — | — | US | disclosed |
| CN-113226381-B | Naphthalene derivative conjugated metal oxide nanoparticles as contrast agents for detection of beta-amyloid plaques by magnetic resonance imaging | 古巴神经科学中心 | 2023-09-19 | — | — | CN | disclosed |
| US-20230235093-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND FILMS MADE THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2023-07-27 | — | — | US | disclosed |
| CN-114957119-B | Tetrahydroquinoline spiro 1, 3-indene diketone derivative and preparation method and application thereof | 武汉大学中南医院 | 2023-06-16 | — | — | CN | disclosed |
| US-11674059-B2 | Styrene butadiene rubber latex compositions and methods for making and using same | Lion Copolymers Holdings, LLC (US) | 2023-06-13 | — | — | US | disclosed |
| US-20230150980-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | ANIMA BIOTECH INC. (US) | 2023-05-18 | — | — | US | disclosed |
| US-11643477-B2 | Regioselectively substituted cellulose esters and films made therefrom | EASTMAN CHEMICAL COMPANY (US) | 2023-05-09 | — | — | US | disclosed |
| US-20230136718-A1 | FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS | Alzeca Biosciences, LLC (US) | 2023-05-04 | — | — | US | disclosed |
| EP-4139291-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | Anima Biotech Inc. (US) | 2023-03-01 | — | — | EP | disclosed |
| CN-112898508-B | Fluorosiloxane polyolefin copolymer and preparation method thereof | 浙江飞翼光电科技股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| US-20220389287-A1 | STYRENE BUTADIENE RUBBER LATEX COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | LION COPOLYMER HOLDINGS, LLC (US) | 2022-12-08 | — | — | US | disclosed |
| CN-115427404-A | Collagen 1 translation inhibitors and methods of use thereof | 艾尼莫生物科技公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-115368713-A | Antibacterial injection molding for automotive interior and preparation method thereof | 扬州维辰汽车电子有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-115368713-A | Antibacterial injection molding for automotive interior and preparation method thereof | 扬州维辰汽车电子有限公司 | 2022-11-22 | — | — | CN | disclosed |
| EP-3894416-B1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2022-11-09 | — | — | EP | disclosed |
| EP-3894416-B1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS INC (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-115216100-A | Anti-ultraviolet injection molding part for automobile interior and preparation method thereof | 扬州维辰汽车电子有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-115216100-A | Anti-ultraviolet injection molding part for automobile interior and preparation method thereof | 扬州维辰汽车电子有限公司 | 2022-10-21 | — | — | CN | disclosed |
| EP-3553097-B1 | COPOLYMER AND OPTICAL FILM USING SAME | TOSOH CORP (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-11286243-B2 | Ferroportin inhibitors and methods of use | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| US-20220041777-A1 | RESIN COMPOSITION FOR OPTICAL SHAPING | KURARAY NORITAKE DENTAL INC. (JP) | 2022-02-10 | — | — | US | disclosed |
| US-11225540-B2 | Copolymer and optical film using same | TOSOH CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| WO-2021216665-A9 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | ANIMA BIOTECH INC. (US) | 2021-12-02 | — | — | WO | disclosed |
| WO-2021216665-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | ANIMA BIOTECH INC. (US) | 2021-10-28 | — | — | WO | disclosed |
| EP-3900693-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | Kuraray Noritake Dental Inc. (JP) | 2021-10-27 | — | — | EP | disclosed |
| EP-3894416-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | Global Blood Therapeutics, Inc. (US) | 2021-10-20 | — | — | EP | disclosed |
| US-20210290782-A1 | METAL OXIDES NANOPARTICLES CONJUGATED WITH NAPHTHALENE DERIVATIVES AS CONTRAST AGENTS FOR THE DETECTION OF BETA AMYLOID PLAQUES BY MAGNETIC RESONANCE IMAGES | CENTRO DE NEUROCIENCIAS DE CUBA (CU) | 2021-09-23 | — | — | US | disclosed |
| EP-3878475-A1 | METAL OXIDES NANOPARTICLES CONJUGATED WITH NAPHTHALENE DERIVATIVES AS CONTRAST AGENTS FOR THE DETECTION OF BETA AMYLOID PLAQUES BY MAGNETIC RESONANCE IMAGES | Centro De Neurociencias De Cuba (CU) | 2021-09-15 | — | — | EP | disclosed |
| CN-113226247-A | Resin composition for stereolithography | 可乐丽则武齿科株式会社 | 2021-08-06 | — | — | CN | disclosed |
| CN-112898508-A | Fluorosiloxane polyolefin copolymer and preparation method thereof | 浙江飞翼光电科技股份有限公司 | 2021-06-04 | — | — | CN | disclosed |
| US-10875996-B2 | Methacrylic copolymer and molded article | KURARAY CO., LTD. (JP) | 2020-12-29 | — | — | US | disclosed |
| US-20200317902-A1 | METHACRYLIC COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2020-10-08 | — | — | US | disclosed |
| US-20200261605-A1 | FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS | Alzeca Biosciences, LLC | 2020-08-20 | — | — | US | disclosed |
| WO-2020129736-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | クラレノリタケデンタル株式会社 | 2020-06-25 | — | — | WO | disclosed |
| US-20200190045-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-06-18 | — | — | US | disclosed |
| WO-2020123850-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020123850-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| US-20200190045-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | GLOBAL BLOOD THERAPEUTICS, INC. | 2020-06-18 | — | — | US | disclosed |
| US-20200095358-A1 | COPOLYMER AND OPTICAL FILM USING SAME | TOSOH CORPORATION (JP) | 2020-03-26 | — | — | US | disclosed |
| EP-3564275-A1 | METHACRYLIC COPOLYMER AND MOLDED ARTICLE | Kuraray Co., Ltd. (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3553097-A1 | COPOLYMER AND OPTICAL FILM USING SAME | Tosoh Corporation (JP) | 2019-10-16 | — | — | EP | disclosed |
| EP-2957579-B1 | COPOLYMER AND MOLDED BODY | KURARAY CO (JP) | 2019-10-02 | — | — | EP | disclosed |
| US-10407524-B2 | Copolymer and molded article | KURARAY CO., LTD. (JP) | 2019-09-10 | — | — | US | disclosed |
| CN-109843935-A | Dispersion liquid | 住友化学株式会社 | 2019-06-04 | — | — | CN | disclosed |
| CN-109844620-A | Near infrared light with low residual color ends optical goods | 依视路国际公司 | 2019-06-04 | — | — | CN | disclosed |
| US-10287380-B2 | Copolymer, and molded article | KURARAY CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| CN-106459241-B | Water-based emulsion and film, solidfied material and laminated body | 住友化学株式会社 | 2019-03-01 | — | — | CN | disclosed |
| CN-108822574-A | Heteroaryl ethylene class new small molecule solar cell material | 北京化工大学 | 2018-11-16 | — | — | CN | disclosed |
| EP-3095800-B1 | COPOLYMER, AND MOLDED ARTICLE | KURARAY CO (JP) | 2018-05-02 | — | — | EP | disclosed |
| EP-2627178-B1 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS | MERCK SHARP & DOHME (US) | 2018-05-02 | — | — | EP | disclosed |
| US-9856342-B2 | Copolymer and molded body | KURARAY CO., LTD. (JP) | 2018-01-02 | — | — | US | disclosed |
| CN-103596950-B | There is the compound of compatibility to amyloid | 日本医事物理股份有限公司 | 2017-12-19 | — | — | CN | disclosed |
| US-20170306054-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND FILMS MADE THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2017-10-26 | — | — | US | disclosed |
| US-20170307796-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS AND FILMS MADE THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2017-10-26 | — | — | US | disclosed |
| US-20170226249-A1 | COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20170174802-A1 | COPOLYMER AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2017-06-22 | — | — | US | disclosed |
| EP-3181602-A1 | COPOLYMER AND MOLDED ARTICLE | Kuraray Co., Ltd. (JP) | 2017-06-21 | — | — | EP | disclosed |
| EP-2042501-B1 | COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDIPHYSICS CO LTD (JP) | 2017-04-12 | — | — | EP | disclosed |
| EP-2716641-B1 | RADIOACTIVE IODINE LABELED COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDIPHYSICS CO LTD (JP) | 2017-04-05 | — | — | EP | disclosed |
| EP-2725027-B1 | NOVEL COMPOUND WITH AMYLOID AFFINITY | NIHON MEDIPHYSICS CO LTD (JP) | 2017-03-01 | — | — | EP | disclosed |
| EP-3095800-A1 | COPOLYMER, AND MOLDED ARTICLE | Kuraray Co., Ltd. (JP) | 2016-11-23 | — | — | EP | disclosed |
| US-20160326288-A1 | COPOLYMER, AND MOLDED ARTICLE | KURARAY CO., LTD. (JP) | 2016-11-10 | — | — | US | disclosed |
| US-20160002380-A1 | COPOLYMER AND MOLDED BODY | KURAKAY CO., LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2957579-A1 | COPOLYMER AND MOLDED BODY | Kuraray Co., Ltd. (JP) | 2015-12-23 | — | — | EP | disclosed |
| US-9211350-B2 | Compound with amyloid affinity | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2015-12-15 | — | — | US | disclosed |
| US-9149546-B2 | Compound having affinity for amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20150202185-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | TAIJI BIOMEDICAL, INC. | 2015-07-23 | — | — | US | disclosed |
| US-9023845-B2 | Compositions and methods for treating lysosomal disorders | NEURALTUS PHARMACEUTICALS, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-9000111-B2 | Thermoplastic resin, organic-inorganic hybrid composition and optical parts | FUJIFILM CORPORATION (JP) | 2015-04-07 | — | — | US | disclosed |
| US-9000111-B2 | Thermoplastic resin, organic-inorganic hybrid composition and optical parts | FUJIFILM CORPORATION (JP) | 2015-04-07 | — | — | US | disclosed |
| US-20150044193-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION | NEURALTUS PHARMACEUTICALS, INC. | 2015-02-12 | — | — | US | disclosed |
| US-8927559-B2 | Quinazolinone-type compounds as CRTH2 antagonists | MERCK SHARP & DOHME CORP. (US) | 2015-01-06 | — | — | US | disclosed |
| US-8927559-B2 | Quinazolinone-type compounds as CRTH2 antagonists | MERCK SHARP & DOHME CORP. (US) | 2015-01-06 | — | — | US | disclosed |
| US-8927559-B2 | Quinazolinone-type compounds as CRTH2 antagonists | MERCK SHARP & DOHME CORP. (US) | 2015-01-06 | — | — | US | disclosed |
| US-20140228569-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2014-08-14 | — | — | US | disclosed |
| US-20140121377-A1 | NOVEL COMPOUND WITH AMYLOID AFFINITY | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2014-05-01 | — | — | US | disclosed |
| EP-2725027-A1 | NOVEL COMPOUND WITH AMYLOID AFFINITY | Nihon Medi-Physics Co., Ltd. (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-1408059-B1 | Latex and its preparation | SYNTHOMER DEUTSCHLAND GMBH (DE) | 2014-04-23 | — | — | EP | disclosed |
| US-20130210805-A1 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS | MERCK SHARP & DOHME LLC | 2013-08-15 | — | — | US | disclosed |
| US-20130210805-A1 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS | MERCK SHARP & DOHME LLC | 2013-08-15 | — | — | US | disclosed |
| US-20130210805-A1 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS | MERCK SHARP & DOHME LLC | 2013-08-15 | — | — | US | disclosed |
| US-8506930-B2 | Compounds having affinity for amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2013-08-13 | — | — | US | disclosed |
| US-8399672-B2 | Compound having affinity for amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20130012539-A1 | Compositions and Methods for Treating Lysosomal Disorders | THE HOSPITAL FOR SICK CHILDREN (CA) | 2013-01-10 | — | — | US | disclosed |
| WO-2012176587-A1 | NOVEL COMPOUND WITH AMYLOID AFFINITY | 日本メジフィジックス株式会社 (JP) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012161116-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | 日本メジフィジックス株式会社 (JP) | 2012-11-29 | — | — | WO | disclosed |
| US-8303935-B2 | Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20120271053-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2012-10-25 | — | — | US | disclosed |
| US-8277777-B2 | Compound having affinity for amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| CN-102659708-A | Structure and preparation method for heterocyclic aryl acetylene compounds containing benzoxazole and benzothiazole groups | UNIV BEIJING CHEMICAL | 2012-09-12 | — | — | CN | disclosed |
| US-8252789-B2 | Compositions and methods for treating lysosomal disorders | NEURALTUS PHARMACEUTICALS, INC. (US) | 2012-08-28 | — | — | US | disclosed |
| CN-101501033-B | Compounds having affinity for amyloid | GE HEALTHCARE LTD | 2012-08-01 | — | — | CN | disclosed |
| US-8207189-B2 | Compound having affinity for amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| WO-2011029443-A8 | DEVICE FOR A MULTIPLE SOCKET FOR RECEIVING PLUG CONNECTIONS | HOHENADEL THORSTEN (DE) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012051036-A1 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2012-04-19 | — | — | WO | disclosed |
| US-20120052053-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION | THE PARKINSON'S INSTITUTE | 2012-03-01 | — | — | US | disclosed |
| EP-2019103-B1 | COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDIPHYSICS CO LTD (JP) | 2011-11-30 | — | — | EP | disclosed |
| CN-102256785-A | Laminated body, manufacturing method thereof, and laminated circuit board | TOYO BOSEKI | 2011-11-23 | — | — | CN | disclosed |
| EP-2098522-B1 | COMPOUNDS HAVING AFFINITY FOR AMYLOID | NIHON MEDIPHYSICS CO LTD (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-8022207-B2 | Compound having affinity to amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2011-09-20 | — | — | US | disclosed |
| EP-2361089-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED -SYNUCLEIN FUNCTION | Parkinson's Institute (US) | 2011-08-31 | — | — | EP | disclosed |
| US-20110201808-A1 | NOVEL COMPOUND HAVING AFFINITY TO AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2011-08-18 | — | — | US | disclosed |
| US-20110135903-A1 | THERMOPLASTIC RESIN, ORGANIC-INORGANIC HYBRID COMPOSITION AND OPTICAL PARTS | FUJIFILM CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110135903-A1 | THERMOPLASTIC RESIN, ORGANIC-INORGANIC HYBRID COMPOSITION AND OPTICAL PARTS | FUJIFILM CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2022792-B1 | NOVEL COMPOUND HAVING AFFINITY TO AMYLOID | NIHON MEDIPHYSICS CO LTD (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20100292479-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-11-18 | — | — | US | disclosed |
| US-20100267952-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100249408-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100249419-A1 | UTILIZATION OF NOVEL COMPOUNDS WITH AMYLOID AFFINITY AND METHOD OF PRODUCING THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100249407-A1 | Novel Compound Having Affinity to Amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100249418-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100216994-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2218463-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-18 | — | — | EP | disclosed |
| EP-2216051-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| EP-2216052-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| EP-2216050-A1 | UTILIZATION OF NOVEL COMPOUNDS WITH AMYLOID AFFINITY AND METHOD OF PRODUCING THE SAME | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-11 | — | — | EP | disclosed |
| EP-2211856-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | The Hospital For Sick Children (CA) | 2010-08-04 | — | — | EP | disclosed |
| EP-2213672-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-04 | — | — | EP | disclosed |
| EP-2213671-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | Nihon Medi-Physics Co., Ltd. (JP) | 2010-08-04 | — | — | EP | disclosed |
| WO-2010056413-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED α-SYNUCLEIN FUNCTION | PARKINSON'S INSTITUTE (US) | 2010-05-20 | — | — | WO | disclosed |
| US-20100092387-A1 | Novel Compound Having Affinity For Amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20100074863-A1 | ANTI-INFECTIVE PYRROLIDINE DERIVATIVES AND ANALOGS | ENANTA PHARMACEUTICALS, INC. | 2010-03-25 | — | — | US | disclosed |
| US-20100069640-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS COL, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| CN-100577642-C | Aluminium and copper metallized insulated material | INFINEON TECHNOLOGIES AG | 2010-01-06 | — | — | CN | disclosed |
| EP-1205815-B1 | Liquid inks comprising surface-treated colorant particles and manufacturing method thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2009-12-23 | — | — | EP | disclosed |
| CN-101595108-A | Novel compound having affinity for amyloid | NIHON MEDIPHYSICS CO LTD (JP) | 2009-12-02 | — | — | CN | disclosed |
| US-20090252680-A1 | NOVEL COMPOUND WITH AFFINITY FOR AMYLOID | NIHON- MEDI-PHYSICS CO., LTD (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090252679-A1 | Novel Compound Having Affinity for Amyloid | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-10-08 | — | — | US | disclosed |
| CN-101535309-A | Novel compound having affinity for amyloid | NIHON MEDIPHYSICS CO LTD (JP) | 2009-09-16 | — | — | CN | disclosed |
| EP-2098522-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-09-09 | — | — | EP | disclosed |
| EP-2098523-A1 | NOVEL COMPOUNDS WITH AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-09-09 | — | — | EP | disclosed |
| CN-101501033-A | Novel compound having affinity for amyloid | NIHON MEDIPHYSICS CO LTD (JP) | 2009-08-05 | — | — | CN | disclosed |
| CN-101472923-A | Novel compound having affinity to amyloid | NIHON MEDIPHYSICS CO LTD (JP) | 2009-07-01 | — | — | CN | disclosed |
| US-20090163500-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-06-25 | — | — | US | disclosed |
| CN-101466711-A | Novel compound having affinity for amyloid | NIHON MEDIPHYSICS CO LTD (JP) | 2009-06-24 | — | — | CN | disclosed |
| WO-2009073564-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-06-11 | — | — | WO | disclosed |
| EP-2042501-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-20090060874-A1 | BICYCLIC PYRROLIDINE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2009-03-05 | — | — | US | disclosed |
| US-20090047247-A1 | Pyrrolidine Derivatives | ENANTA PHARMACEUTICALS, INC. | 2009-02-19 | — | — | US | disclosed |
| EP-2022792-A1 | NOVEL COMPOUND HAVING AFFINITY TO AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-02-11 | — | — | EP | disclosed |
| EP-2019103-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-01-28 | — | — | EP | disclosed |
| US-20090022689-A1 | C4-SPIRO-PYRROLIDINE ANTIVIRALS | ENANTA PHARMACEUTICALS, INC. | 2009-01-22 | — | — | US | disclosed |
| US-20090004140-A1 | 4-SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES | ENANTA PHARMACEUTICALS, INC. | 2009-01-01 | — | — | US | disclosed |
| WO-2009003009-A1 | SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| EP-1327915-B1 | Liquid inks comprising stabilizing organosols | SAMSUNG ELECTRONICS CO LTD (KR) | 2008-12-10 | — | — | EP | disclosed |
| US-20070203215-A1 | Methods & Compositions For Enhancing Pharmaceutical Treatments | TAIJI BIOMEDICAL, INC. (US) | 2007-08-30 | — | — | US | disclosed |
| US-7259193-B2 | Liquid ink composition and method of producing a liquid ink composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-08-21 | — | — | US | disclosed |
| EP-1229057-B1 | Organosol and liquid inks comprising the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-05-23 | — | — | EP | disclosed |
| US-20060270773-A1 | Polyester-polycarbonate blends for diffuser sheets with improved luminance | EASTMAN CHEMICAL COMPANY | 2006-11-30 | — | — | US | disclosed |
| US-20060270806-A1 | Miscible high Tg polyester/polymer blend compositions and films formed therefrom | EASTMAN CHEMICAL COMPANY | 2006-11-30 | — | — | US | disclosed |
| WO-2006127755-A2 | POLYESTER-POLYCARBONATE BLENDS FOR DIFFUSER SHEETS WITH IMPROVED LUMINANCE | EASTMAN CHEMICAL COMPANY (US) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006127831-A1 | MISCIBLE HIGH TG POLYESTER/POLYMER BLEND COMPOSITIONS AND FILMS FORMED THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2006-11-30 | — | — | WO | disclosed |
| US-7101927-B2 | Latex obtainable by a gradient regime reaction | STERNAGEL FLEISCHER GODEMEYER & PARTNER (DE) | 2006-09-05 | — | — | US | disclosed |
| US-7098265-B2 | Liquid inks comprising a stable organosol | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-08-29 | — | — | US | disclosed |
| US-20050160938-A1 | Liquid inks comprising stabilizing organosols | SAMSUNG ELECTRONICS CO., LTD. | 2005-07-28 | — | — | US | disclosed |
| US-6905807-B2 | Liquid inks comprising stabilizing organosols | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-06-14 | — | — | US | disclosed |
| US-6894117-B2 | Non-gelled product of addition and condensation polymers with mutually reactive groups | JOHNSON POLYMER, INC. (US) | 2005-05-17 | — | — | US | disclosed |
| US-20050075417-A1 | Liquid ink composition and method of producing a liquid ink composition | S-PRINTING SOLUTION CO., LTD. (KR) | 2005-04-07 | — | — | US | disclosed |
| US-20050043545-A1 | 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors | GLAXO GROUP LIMITED (GB) | 2005-02-24 | — | — | US | disclosed |
| EP-0986611-B1 | CROSS-LINKABLE SURFACE COATINGS AND PROCESS OF PREPARATION | JOHNSON POLYMER LLC (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20050009952-A1 | Liquid inks comprising a stable organosol | SAMSUNG ELECTRONICS CO. LTD. | 2005-01-13 | — | — | US | disclosed |
| US-6828358-B2 | Dispersing pigment particles in a solution of a nitrogen-containing polymerizable monomer in a solvent with a Kauri-Butanol number <30; desolventizing; dispersing the surface-treated particles in an organosol (K-B >30) | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-12-07 | — | — | US | disclosed |
| EP-0999835-A4 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | ONTOGEN CORP (US) | 2004-08-25 | — | — | EP | disclosed |
| EP-1440070-A1 | 4-(5-MEMBERED)-HETEROARYL ACYL PYRROLIDINE DERIVATIVES AS HCV INHIBITORS | GLAXO GROUP LIMITED (GB) | 2004-07-28 | — | — | EP | disclosed |
| US-20040138385-A1 | Polymeric compositions, and the preparation and use thereof | BASF CORPORATION | 2004-07-15 | — | — | US | disclosed |
| US-20040072945-A1 | Latex and its preparation | STERNAGEL FLEISCHER GODEMEYER & PARTNER (DE) | 2004-04-15 | — | — | US | disclosed |
| EP-1408059-A1 | Latex and its preparation | Polymer Latex GmbH & Co. KG (DE) | 2004-04-14 | — | — | EP | disclosed |
| US-6696522-B2 | UNGELLED REACTION PRODUCT OF AN ADDITION POLYMER HAVING PENDANT REACTIVE GROUPS AND A CONDENSATION POLYMER WHOSE GROUPS REACT WITH THOSE PENDANT REACTION GROUPS; DEGLOSSING A POWDER COATING | JOHNSON POLYMER, INC. | 2004-02-24 | — | — | US | disclosed |
| CN-1472195-A | Aluminium and steel metallized insulated material | 因芬尼昂技术股份公司 | 2004-02-04 | — | — | CN | disclosed |
| US-6649316-B2 | Crystallizable polymeric binder resin and the phase change developer reversibly changes from solid phase to liquid phase at or above 22 degrees C. | SAMSUNG ELECTRONICS CO. LTD (KR) | 2003-11-18 | — | — | US | disclosed |
| EP-1030889-B1 | POLYMERIC COMPOSITIONS, AND THE PREPARATION AND USE THEREOF | JOHNSON DIVERSEY INC (US) | 2003-07-23 | — | — | EP | disclosed |
| US-20030134940-A1 | Liquid inks comprising stabilizing organosols | SAMSUNG ELECTRONICS CO., LTD. | 2003-07-17 | — | — | US | disclosed |
| EP-1327915-A1 | Liquid inks comprising stabilizing organosols | Samsung Electronics Co., Ltd. (KR) | 2003-07-16 | — | — | EP | disclosed |
| WO-2003037894-A1 | 4-(5-MEMBERED)-HETEROARYL ACYL PYRROLIDINE DERIVATIVES AS HCV INHIBITORS | GLAXO GROUP LIMITED (GB) | 2003-05-08 | — | — | WO | disclosed |
| US-20020197552-A1 | Phase change developer for liquid electrophotography | SAMSUNG | 2002-12-26 | — | — | US | disclosed |
| US-20020156188-A1 | Polymeric compositions, and the preparation and use thereof | BASF CORPORATION | 2002-10-24 | — | — | US | disclosed |
| EP-1251406-A2 | Phase change developer for liquid electrophotography and method for electrophotographic imaging using the same | Samsung Electronics Co., Ltd. (KR) | 2002-10-23 | — | — | EP | disclosed |
| US-20020147197-A1 | Methods and compositions for enhancing pharmaceutical treatments | TAIJI BIOMEDICAL, INC. | 2002-10-10 | — | — | US | disclosed |
| US-20020128349-A1 | Liquid inks comprising a stable organosol | S-PRINTING SOLUTION CO., LTD. (KR) | 2002-09-12 | — | — | US | disclosed |
| EP-1229057-A2 | Organosol and liquid inks comprising the same | Samsung Electronics Co., Ltd. (KR) | 2002-08-07 | — | — | EP | disclosed |
| EP-1030891-B1 | SOLVENT BASED COMPOSITIONS CONTAINING A SUBSTANTIALLY NON-GELLED POLYMERIC COMPOSITION | JOHNSON S C COMM MARKETS INC (US) | 2002-07-17 | — | — | EP | disclosed |
| US-20020086916-A1 | Liquid inks comprising treated colorant particles | SAMSUNG | 2002-07-04 | — | — | US | disclosed |
| EP-1205815-A1 | Liquid inks comprising surface-treated colorant particles and manufacturing method thereof | Samsung Electronics Co., Ltd. (KR) | 2002-05-15 | — | — | EP | disclosed |
| US-6372841-B1 | SOLVENT FOR POLYMER GELS | S. C. JOHNSON COMMERCIAL MARKETS, INC. | 2002-04-16 | — | — | US | disclosed |
| EP-1030890-B1 | WATER DISPERSIBLE POLYMERIC COMPOSITIONS | JOHNSON S C COMM MARKETS INC (US) | 2002-03-20 | — | — | EP | disclosed |
| US-6316538-B1 | USEFUL IN OR AS OVERPRINT VARNISHES, INKS, PIGMENT DISPERSIONS, PAINTS, ADHESIVES, COATINGS, SUPPORT RESINS | S. C. JOHNSON COMMERICAL MARKETS, INC. | 2001-11-13 | — | — | US | disclosed |
| US-6194510-B1 | USEFUL IN OR AS OVERPRINT VARNISHES, INKS, PIGMENT DISPERSIONS, PAINTS, ADHESIVES, COATINGS, SUPPORT RESINS, EMULSION POLYMERS AND THE LIKE | S. C. JOHNSON COMMERCIAL MARKETS, INC. | 2001-02-27 | — | — | US | disclosed |
| US-6162860-A | Solvent based interactive polymeric compositions containing a substantially non-gelled composition | S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| EP-1030890-A1 | WATER DISPERSIBLE POLYMERIC COMPOSITIONS | S.C. Johnson Commercial Markets, Inc. (US) | 2000-08-30 | — | — | EP | disclosed |
| EP-1030889-A2 | POLYMERIC COMPOSITIONS, AND THE PREPARATION AND USE THEREOF | S.C. Johnson Commercial Markets, Inc. (US) | 2000-08-30 | — | — | EP | disclosed |
| EP-1030891-A1 | SOLVENT BASED COMPOSITIONS CONTAINING A SUBSTANTIALLY NON-GELLED POLYMERIC COMPOSITION | S.C. Johnson Commercial Markets, Inc. (US) | 2000-08-30 | — | — | EP | disclosed |
| US-6090882-A | Crosslinkable surface coatings and process of preparation | S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0853636-B1 | SEED POLYMERIZED LATEX POLYMER HAVING A GRADIENT POLYMERIC MORPHOLOGY AND PROCESS FOR PREPARING THE SAME | JOHNSON S C COMM MARKETS INC (US) | 2000-05-31 | — | — | EP | disclosed |
| EP-0999835-A1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | Ontogen Corporation (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0986611-A1 | CROSS-LINKABLE SURFACE COATINGS AND PROCESS OF PREPARATION | S.C. Johnson Commercial Markets, Inc. (US) | 2000-03-22 | — | — | EP | disclosed |
| US-5953566-A | Color image forming method and apparatus providing for efficient toner transfer based on toner zeta potentials | MINOLTA CO., LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| CN-1225672-A | Detergent composition | PROCTER & GAMBLE (US) | 1999-08-11 | — | — | CN | disclosed |
| WO-1999028389-A1 | SOLVENT BASED COMPOSITIONS CONTAINING A SUBSTANTIALLY NON-GELLED POLYMERIC COMPOSITION | S.C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 1999-06-10 | — | — | WO | disclosed |
| WO-1999024510-A1 | WATER DISPERSIBLE POLYMERIC COMPOSITIONS | S.C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 1999-05-20 | — | — | WO | disclosed |
| WO-1999024485-A2 | POLYMERIC COMPOSITIONS, AND THE PREPARATION AND USE THEREOF | S.C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 1999-05-20 | — | — | WO | disclosed |
| US-5883259-A | HAVING HIGH THERMAL RESISTANCE AND CAN BE USED FOR OPTICAL DEVICES SUCH AS ELECTRO-OPTIC MODULATOR, OPTICAL SWITCH, OR THE LIKE FOR TREATING OPTICAL SIGNAL IN OPTICAL COMMUNICATION INDUSTRY | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1999-03-16 | — | — | US | disclosed |
| WO-1999002155-A1 | IMIDAZOLE DERIVATIVES AS MDR MODULATORS | ONTOGEN CORPORATION (US) | 1999-01-21 | — | — | WO | disclosed |
| WO-1998054256-A1 | CROSS-LINKABLE SURFACE COATINGS AND PROCESS OF PREPARATION | S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| US-5840721-A | INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS | ONTOGEN CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0853636-A1 | SEED POLYMERIZED LATEX POLYMER HAVING A GRADIENT POLYMERIC MORPHOLOGY AND PROCESS FOR PREPARING THE SAME | S.C.JOHNSON COMMERCIAL MARKETS, INC. (US) | 1998-07-22 | — | — | EP | disclosed |
| US-5756573-A | Seed polymerized latex polymer having a gradient polymeric morphology and process for preparing the same | SC JOHNSON COMMERICAL MARKETS, INC. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5724629-A | Liquid developer monitoring device, liquid developer controlling system, and image forming apparatus using same | MINOLTA CO., LTD. (JP) | 1998-03-03 | — | — | US | disclosed |
| US-5689779-A | Liquid developer and developing method and developing apparatus using same | MINOLTA CO., LTD. (JP) | 1997-11-18 | — | — | US | disclosed |
| WO-1997012921-A1 | SEED POLYMERIZED LATEX POLYMER HAVING A GRADIENT POLYMERIC MORPHOLOGY AND PROCESS FOR PREPARING THE SAME | S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) | 1997-04-10 | — | — | WO | disclosed |
| US-4966825-A | Containing an ethylenic copolymer and dielectric | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-30 | — | — | US | disclosed |
| US-4732887-A | RESIN IN VOIDS FOR CHROMATOGRAPHY | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1988-03-22 | — | — | US | disclosed |
| US-4522998-A | VINYL ESTER, ALPHA-OLEFIN, AND VINYLCYCLOPROPANEDICARBOXYLATE POLYESTER | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1985-06-11 | — | — | US | disclosed |
| US-4522999-A | WITH UNSATURATED ESTER | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1985-06-11 | — | — | US | disclosed |
| US-4409355-A | EMULSION POLYMERIZATION | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1983-10-11 | — | — | US | disclosed |
| JP-S5825361-A | FLUORESCENT BRIGHTENER COMPOSITION | NIPPON KAYAKU CO LTD | 1983-02-15 | — | — | JP | disclosed |
| US-4287277-A | CONTAINING A CROSSLINKABLE POLYMER HAVING A HETEROCYCLIC RING, AND A HALOGEN COMPOUND ACTIVATED BY RADIATION | CANON KABUSHIKI KAISHA (JP) | 1981-09-01 | — | — | US | disclosed |
| US-4258111-A | Hologram and method of production thereof with photo-crosslinkable polymers | CANON KABUSHIKI KAISHA (JP) | 1981-03-24 | — | — | US | disclosed |
| US-4245007-A | OPTICAL BRIGHTENERS | CIBA-GEIGY CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
| US-4192684-A | Photosensitive compositions containing hydrogenated 1,2-polybutadiene | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1980-03-11 | — | — | US | disclosed |
| US-4172724-A | POLYMER AND HALOGEN COMPOUND | CANON KABUSHIKI KAISHA (JP) | 1979-10-30 | — | — | US | disclosed |
| US-4137279-A | COATINGS, FILMS, MOLDING MATERIALS | UNION CARBIDE CORPORATION (US) | 1979-01-30 | — | — | US | disclosed |
| US-4130523-A | High solids latexes | UNION CARBIDE CORPORATION (US) | 1978-12-19 | — | — | US | disclosed |
| US-4093570-A | CROSSLINKABLE, MIXED ORGANIC MEDIUM; | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1978-06-06 | — | — | US | disclosed |
| US-4039500-A | EMULSION POLYMERIZATION, CROSSLINKING | UNION CARBIDE CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |
| US-4039500-A | EMULSION POLYMERIZATION, CROSSLINKING | UNION CARBIDE CORPORATION (US) | 1977-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (36 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210805-A1 | QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS | HRH2, NR3C2, HRH1 | SNCA 4576/4885HDAC3 1264/4885HDAC4 2005/4885 |
| US-20100069640-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | APP, APBA1, C1QBP | SNCA 14/4885HDAC3 4279/4885HDAC4 3730/4885 |
| US-20120052053-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION | SNCA, PARK7, NLN | SNCA 1/4885HDAC3 2868/4885HDAC4 2669/4885 |
| US-20230150980-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | COL1A1, COL2A1, COL14A1 | SNCA 3414/4885HDAC3 3246/4885HDAC4 2141/4885 |
| US-20110201808-A1 | NOVEL COMPOUND HAVING AFFINITY TO AMYLOID | APBA1, APP, BACE1 | SNCA 6/4885HDAC3 4235/4885HDAC4 3778/4885 |
| US-20090163500-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | GAA, GBA1, LIPA | SNCA 2168/4885HDAC3 89/4885HDAC4 97/4885 |
| US-20210290782-A1 | METAL OXIDES NANOPARTICLES CONJUGATED WITH NAPHTHALENE DERIVATIVES AS CONTRAST AGENTS FOR THE DETECTION OF BETA AMYLOID PLAQUES BY MAGNETIC RESONANCE IMAGES | L1CAM, NUCB2, TSPO | SNCA 10/4885HDAC3 3280/4885HDAC4 3649/4885 |
| US-20050043545-A1 | 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors | NR1H3, NR1H2, NR1I3 | SNCA 4172/4885HDAC3 87/4885HDAC4 588/4885 |
| US-20140228569-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | APP, APBA1, BACE1 | SNCA 50/4885HDAC3 4109/4885HDAC4 4044/4885 |
| US-20090004140-A1 | 4-SUBSTITUTED PYRROLIDINE AS ANTI-INFECTIVES | EIF2AK2, RNGTT, POLR2E | SNCA 3713/4885HDAC3 442/4885HDAC4 290/4885 |
| US-20090022689-A1 | C4-SPIRO-PYRROLIDINE ANTIVIRALS | ZC3HAV1, HAVCR2, HCCS | SNCA 2319/4885HDAC3 200/4885HDAC4 195/4885 |
| US-20230136718-A1 | FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS | APBA1, LYPLAL1, APOL1 | SNCA 484/4885HDAC3 4122/4885HDAC4 3932/4885 |
| US-20150044193-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION | SNCA, PARK7, NLN | SNCA 1/4885HDAC3 3320/4885HDAC4 3017/4885 |
| US-20100249418-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | APP, APBA1, C1QBP | SNCA 46/4885HDAC3 3456/4885HDAC4 3636/4885 |
| US-20100249408-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | APBA1, APP, S100A4 | SNCA 14/4885HDAC3 4716/4885HDAC4 4552/4885 |
| US-11286243-B2 | Ferroportin inhibitors and methods of use | SLC40A1, HAMP, SFXN1 | SNCA 1227/4885HDAC3 3654/4885HDAC4 3862/4885 |
| US-20200261605-A1 | FUNCTIONALIZED LIPOSOMES FOR IMAGING MISFOLDED PROTEINS | APBA1, LYPLAL1, APOL1 | SNCA 484/4885HDAC3 4122/4885HDAC4 3932/4885 |
| US-20100216994-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | APBA1, APP, S100A4 | SNCA 10/4885HDAC3 4582/4885HDAC4 4267/4885 |
| US-20100292479-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | APP, APBA1, BACE1 | SNCA 29/4885HDAC3 3569/4885HDAC4 3860/4885 |
| US-20130012539-A1 | Compositions and Methods for Treating Lysosomal Disorders | GAA, GBA1, LIPA | SNCA 2168/4885HDAC3 89/4885HDAC4 97/4885 |
| US-20100249407-A1 | Novel Compound Having Affinity to Amyloid | APBA1, APP, BACE1 | SNCA 6/4885HDAC3 4235/4885HDAC4 3778/4885 |
| US-12311036-B2 | Metal oxides nanoparticles conjugated with naphthalene derivatives as contrast agents for the detection of beta amyloid plaques by magnetic resonance images | L1CAM, NUCB2, TSPO | SNCA 10/4885HDAC3 3280/4885HDAC4 3649/4885 |
| US-20100074863-A1 | ANTI-INFECTIVE PYRROLIDINE DERIVATIVES AND ANALOGS | ZC3HAV1, POLRMT, EIF2AK2 | SNCA 3639/4885HDAC3 424/4885HDAC4 647/4885 |
| US-20070203215-A1 | Methods & Compositions For Enhancing Pharmaceutical Treatments | TUBB3, TUBB1, TUBB2A | SNCA 756/4885HDAC3 1561/4885HDAC4 2449/4885 |
| US-20100249419-A1 | UTILIZATION OF NOVEL COMPOUNDS WITH AMYLOID AFFINITY AND METHOD OF PRODUCING THE SAME | APBA1, S100A4, APP | SNCA 56/4885HDAC3 4703/4885HDAC4 4561/4885 |
| US-20020147197-A1 | Methods and compositions for enhancing pharmaceutical treatments | TUBB3, TUBB1, TUBB2A | SNCA 823/4885HDAC3 1155/4885HDAC4 2507/4885 |
| US-20100092387-A1 | Novel Compound Having Affinity For Amyloid | APP, SLC43A1, APBA1 | SNCA 27/4885HDAC3 3907/4885HDAC4 3923/4885 |
| US-20090252680-A1 | NOVEL COMPOUND WITH AFFINITY FOR AMYLOID | APBA1, APP, SLC7A1 | SNCA 8/4885HDAC3 4230/4885HDAC4 3508/4885 |
| US-20090252679-A1 | Novel Compound Having Affinity for Amyloid | APBA1, SAAL1, SLC43A1 | SNCA 22/4885HDAC3 4678/4885HDAC4 4545/4885 |
| US-20090060874-A1 | BICYCLIC PYRROLIDINE DERIVATIVES | EIF2AK2, ZC3HAV1, POLRMT | SNCA 3687/4885HDAC3 200/4885HDAC4 446/4885 |
| US-20140121377-A1 | NOVEL COMPOUND WITH AMYLOID AFFINITY | APP, APBA1, BACE1 | SNCA 83/4885HDAC3 3481/4885HDAC4 3387/4885 |
| US-20150202185-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL DISORDERS | GAA, GBA1, LIPA | SNCA 2168/4885HDAC3 89/4885HDAC4 97/4885 |
| US-20100267952-A1 | USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME | APBA1, APP, SAAL1 | SNCA 12/4885HDAC3 4795/4885HDAC4 4648/4885 |
| US-20200190045-A1 | FERROPORTIN INHIBITORS AND METHODS OF USE | SLC40A1, HAMP, TFRC | SNCA 1944/4885HDAC3 3930/4885HDAC4 4278/4885 |
| US-20090047247-A1 | Pyrrolidine Derivatives | ZC3HAV1, EIF2AK2, POLRMT | SNCA 3420/4885HDAC3 370/4885HDAC4 617/4885 |
| US-20120271053-A1 | NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID | APBA1, SAAL1, SLC43A1 | SNCA 22/4885HDAC3 4678/4885HDAC4 4545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.